Fontenay aux Roses, France

Pierre Desnoyers

This inventor holds 1 USPTO granted patent. Top assignee: Science Union Et Cie. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Desnoyers. Retrieved from https://idiyas.com/inventor/pierre-desnoyers-e5mlpue6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Desnoyers: Innovator in Pharmaceutical Compositions

Introduction

Pierre Desnoyers is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address critical health issues.

Latest Patents

Desnoyers holds 1 patent for his innovative work on pharmaceutical compositions containing gamma-resorcylic acid. This patent focuses on compositions that utilize a gamma-resorcylic acid derivative or a physiologically tolerable salt thereof. These compositions are particularly effective in treating thromboembolic diseases and arteriosclerosis.

Career Highlights

Throughout his career, Desnoyers has been associated with Science Union Et Cie, where he has applied his expertise in pharmaceutical development. His work has contributed to advancements in medical treatments that benefit patients suffering from serious conditions.

Collaborations

Desnoyers has collaborated with notable colleagues, including Gilbert Regnier and Roger Canevari. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Pierre Desnoyers is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve treatment options for various diseases. His contributions to the field exemplify the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…